| HCC recurrence | Test of Sig. | p | |
---|---|---|---|---|
No (n = 31), no. (%) | Yes (n = 19), no. (%) | |||
BCLC | ||||
 0 | 5 (16.1%) | 0 (0.0%) | χ2 = 0.161* | 0.004* |
 A | 21 (67.7%) | 8 (42.1%) | ||
 B | 5 (16.1%) | 11 (57.9%) | ||
HCC treatment | ||||
 Hepatic resection | 5 (16.1%) | 6 (31.5%) | χ2 = 4.989* | p = 0.035* |
 RFA | 16 (51.6%) | 11 (57.8%) | χ2 = 0.693 | p = 0.405 |
 LDLT | 8 (25.8%) | 2 (10.5%) | χ2 = 5.837* | p = 0.018* |
 Alcohol injection | 2 (6.4%) | 0 (0.0%) | χ2 = 0.625 | p = 1.000 |
HCV treatment (weeks) | ||||
 Min.–Max. | 12.0–24.0 | 12.0–24.0 | t = 1.202 | 0.238 |
 Mean ± SD | 13.94 ± 4.49 | 15.79 ± 5.73 | ||
 Median | 12.0 | 12.0 | ||
HCV treatment | ||||
 SOF/DAC | 1 (3.2%) | 0 (0.0%) | χ2 = 0.625 | p = 1.000 |
 SOF/DAC/RBV | 17 (54.8%) | 13 (68.4%) | χ2 = 0.905 | p = 0.341 |
 SOF/LED | 3 (9.7%) | 2 (10.5%) | χ2 = 0.009 | p = 1.000 |
 SOF/LED/RBV | 0 (0.0%) | 1 (5.3%) | χ2 = 1.665 | p = 0.380 |
 SOF/RBV | 6 (19.4%) | 3 (15.8%) | χ2 = 0.101 | p = 1.000 |
 SOF/SIM | 4 (12.9%) | 0 (0.0%) | χ2 = 2.665 | p = 0.284 |
PCR after TTT | ||||
 SVR | 29 (93.5%) | 13 (68.4%) | χ2 = 5.534* | p = 0.041* |
 Relapser | 2 (6.5%) | 6 (31.6%) |